Transgender Women’s Interventions: Pilot and Evaluation
ID: 352288Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCHHSTP (HHS-CDC-NCHHSTP)

Award Range

$8M - $8M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352288
Timeline
    Description

    The Centers for Disease Control - NCHHSTP is forecasting a federal grant opportunity titled "Transgender Women’s Interventions: Pilot and Evaluation," aimed at supporting HIV prevention services specifically for transgender women. This cooperative agreement seeks applications from organizations that are embedded within the transgender community and have a proven history of providing HIV prevention services, with the ability to operate in up to three service areas, including those that may cross state lines. The program is critical for addressing health disparities and improving health outcomes for transgender women, with an estimated total funding of $8.4 million available for up to eight awards, each with a ceiling of $8.4 million. Interested applicants should prepare to submit their proposals electronically by October 9, 2024, and may contact Andrea Moore at AMoore@cdc.gov or 404-639-6262 for further information.

    Point(s) of Contact
    Andrea Moore
    (404) 639-6262
    AMoore@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South." This initiative aims to address the significant health disparities faced by CgBW, who represent the largest percentage of women living with HIV in the U.S., by funding organizations to implement integrated care service models through Community and Clinic Collaboratives (CCCs). The project will focus on providing comprehensive health services, including HIV care, mental health support, and essential services, while fostering culturally responsive practices and sharing best practices through a national learning collaborative. The estimated total program funding is $7.5 million, with three awards expected, and applications must be submitted electronically by March 28, 2025, to be considered for funding. For further inquiries, interested applicants can contact Jerris Raiford at (770) 488-0691 or via email at HRBNOFO@cdc.gov.
    Implementation and Evaluation of PrEPmate: An evidence-based short message service/text-based PrEP intervention for YMSM and Transgender women of color
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the implementation and evaluation of PrEPmate, a mobile health intervention aimed at enhancing HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) and transgender women of color. The initiative seeks to facilitate the deployment of PrEPmate at three clinical sites in the southern United States, focusing on improving patient adherence and retention in PrEP care through tailored interactive content, reminders, and a monitoring dashboard. With an estimated total program funding of $3 million and one expected award, interested applicants can reach out to Charles Collins at cwc4@cdc.gov or by phone at 404-639-0966. The application deadline is set for March 7, 2025, with project commencement anticipated on July 1, 2025.
    Developing and Testing Pilot Prevention Interventions to Reduce Sexual Risk Behavior and Enhance PrEP Use among HIV-negative Black and Hispanic Substance-using Gay, Bisexual, and Other MSM
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity aimed at developing and testing pilot prevention interventions to reduce sexual risk behavior and enhance PrEP use among HIV-negative Black and Hispanic substance-using gay, bisexual, and other men who have sex with men (MSM). This initiative seeks to support the design and implementation of two behavioral interventions, one targeting Black MSM and the other targeting Hispanic MSM, specifically focusing on those who report substance use before or during unprotected anal sex. The funding, which ranges from $400,000 to $475,000 per award, totals an estimated $2,850,000 for two awards, with applications due by February 13, 2025, and anticipated project start dates in September 2025. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836 for further information.
    Integrated HIV Programs for Tennessee Community-Based Organizations to Support Ending the HIV Epidemic in the United States
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Integrated HIV Programs for Tennessee Community-Based Organizations to Support Ending the HIV Epidemic in the United States." This cooperative agreement aims to implement a comprehensive HIV prevention program that complements existing initiatives, such as the Ryan White program, to prevent new HIV infections and improve health outcomes for individuals living with HIV in Tennessee. Community-based organizations (CBOs) are expected to play a crucial role in enhancing service delivery, increasing HIV diagnosis, and facilitating access to preventive and care services. The estimated total program funding is $20 million, with two awards anticipated, and applications must be submitted electronically by February 11, 2025. For further inquiries, interested parties can contact Erica K. Dunbar at 800-232-4636 or via email at NOFOINFO@cdc.gov.
    PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention." This initiative aims to support an implementation research study that evaluates optimal strategies for integrating postexposure prophylaxis (PEP) packs into existing clinical services for HIV and STI prevention, specifically targeting gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW) in communities with high HIV diagnosis rates. The funding, which ranges from $900,000 to $1,200,000 with an estimated total program funding of $4,800,000, is available through a cooperative agreement, with one award expected. Interested applicants, particularly for-profit organizations, should note that applications are due by February 12, 2025, with an estimated award date of August 15, 2025. For further inquiries, contact Amy Yang at AYang@cdc.gov or call 404-718-8836.
    Improving prevention, treatment, and care services for HIV and TB for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at improving prevention, treatment, and care services for HIV and tuberculosis (TB) for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative focuses on providing high-quality HIV clinical services, particularly for individuals of Haitian descent, by enhancing access to HIV testing, treatment, and TB preventive therapy, while ensuring lifelong retention in care to achieve viral suppression. This funding is crucial for addressing health disparities and improving health outcomes in vulnerable populations, with an estimated total fiscal year funding amount of $5,600,000 for Year 1, and applications are expected to be submitted electronically by February 17, 2025. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov for further information.
    Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)" aimed at supporting exploratory research on the biological and immunological impacts of medical interventions for transgender individuals. This initiative seeks to address critical gaps in understanding how gender reassignment procedures, including hormone therapy and surgeries, affect susceptibility to HIV and other sexually transmitted infections (STIs), particularly in light of the health disparities faced by this population. Eligible applicants include a wide range of institutions such as higher education, nonprofits, and government entities, with a funding ceiling of $275,000 available over a two-year period. Interested parties must submit their applications by December 7, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    Implement and sustain a comprehensive response to HIV and technical assistance to strengthen the capacity of regional authorities in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at implementing and sustaining a comprehensive response to HIV and providing technical assistance to strengthen the capacity of regional authorities in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative focuses on enhancing service delivery models and fortifying health systems to improve the quality of life for individuals living with HIV, particularly key and vulnerable populations, while striving to meet the UNAIDS 95-95-95 targets. With an anticipated total funding amount of $90 million for the first fiscal year, the CDC expects to award three agreements, with applications due by February 17, 2025, and the estimated award date set for September 30, 2025. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov for further information.
    Building capacity along the continuum from prevention to care and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at enhancing the capacity for HIV prevention, diagnosis, and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR). This initiative will focus on improving access to HIV prevention services, increasing knowledge of HIV status through enhanced testing strategies, and supporting treatment outcomes for individuals living with HIV, particularly in El Salvador, Guatemala, Honduras, Nicaragua, and Panama. The estimated total funding for the first year is approximately $17 million, with the expectation of awarding two grants, and applications must be submitted electronically by February 17, 2025. For further inquiries, interested applicants can contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.
    Supporting the implementation of comprehensive HIV prevention and treatment programs to achieve and sustain epidemic control in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at supporting the implementation of comprehensive HIV prevention and treatment programs in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative seeks to enhance the capacity of the Zimbabwe Ministry of Health and Child Care to deliver critical HIV services, including differentiated testing, treatment linkage, viral load monitoring, and management of advanced HIV disease, while also addressing non-communicable diseases and TB-HIV collaboration. This funding is vital for improving health outcomes among key populations, particularly children and young women, and will involve collaboration with faith-based and government-supported health facilities. Interested applicants can expect an estimated total funding amount of $10 million for the first year, with applications due by February 17, 2025, and the anticipated award date set for September 30, 2025. For further inquiries, applicants may contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.